share_log

Private Companies Invested in Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Copped the Brunt of Last Week's HK$960m Market Cap Decline

Private Companies Invested in Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Copped the Brunt of Last Week's HK$960m Market Cap Decline

私人公司投资于山东威高股份医疗聚合物有限公司(HKG:1066),遭受了上周市值下降96000万港元的冲击。
Simply Wall St ·  2024/11/26 06:58

Key Insights

关键见解

  • The considerable ownership by private companies in Shandong Weigao Group Medical Polymer indicates that they collectively have a greater say in management and business strategy
  • A total of 3 investors have a majority stake in the company with 51% ownership
  • 24% of Shandong Weigao Group Medical Polymer is held by Institutions
  • 私营公司对山东威高集团医用聚合物的大量所有权表明,它们在管理和业务战略中集体拥有更大的发言权
  • 共有3位投资者持有该公司的多数股权,所有权为51%
  • 山东威高集团医用聚合物24%由机构持有

A look at the shareholders of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) can tell us which group is most powerful. The group holding the most number of shares in the company, around 46% to be precise, is private companies. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

看看山东威高集团医用聚合物有限公司(HKG: 1066)的股东可以告诉我们哪个集团最强大。持有该公司股份最多的集团是私营公司,准确地说约为46%。也就是说,如果股票上涨,该集团将受益最大(如果出现低迷,则损失最大)。

As market cap fell to HK$20b last week, private companies would have faced the highest losses than any other shareholder groups of the company.

随着上周市值跌至200亿港元,私营公司面临的损失将超过该公司任何其他股东群体。

Let's take a closer look to see what the different types of shareholders can tell us about Shandong Weigao Group Medical Polymer.

让我们仔细看看不同类型的股东对山东威高集团医用聚合物有什么看法。

big
SEHK:1066 Ownership Breakdown November 25th 2024
SEHK: 1066 所有权明细 2024 年 11 月 25 日

What Does The Institutional Ownership Tell Us About Shandong Weigao Group Medical Polymer?

关于山东威高集团医用聚合物,机构所有权告诉我们什么?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

许多机构根据近似于当地市场的指数来衡量自己的表现。因此,他们通常会更多地关注主要指数中包含的公司。

We can see that Shandong Weigao Group Medical Polymer does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shandong Weigao Group Medical Polymer's earnings history below. Of course, the future is what really matters.

我们可以看到,山东威高集团医用聚合物确实有机构投资者;他们持有该公司很大一部分股票。这意味着在这些机构工作的分析师已经看过这只股票,他们很喜欢。但是就像其他人一样,他们可能错了。如果多家机构同时改变对股票的看法,你可能会看到股价快速下跌。因此,值得在下面查看山东威高集团医用聚合物的收益记录。当然,未来才是真正重要的。

big
SEHK:1066 Earnings and Revenue Growth November 25th 2024
SEHK: 1066 2024年11月25日收益及收入增长

Shandong Weigao Group Medical Polymer is not owned by hedge funds. Weihai Weigao International Medical Investment Holdings Limited is currently the largest shareholder, with 46% of shares outstanding. In comparison, the second and third largest shareholders hold about 3.2% and 2.2% of the stock.

山东威高集团医用聚合物不归对冲基金所有。威海威高国际医疗投资控股有限公司目前是最大股东,有 46% 的已发行股份。相比之下,第二和第三大股东持有约3.2%和2.2%的股份。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

为了使我们的研究更有趣,我们发现前三名股东拥有公司的多数股权,这意味着他们足够强大,足以影响公司的决策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

虽然研究公司的机构所有权可以为您的研究增加价值,但研究分析师的建议以更深入地了解股票的预期表现也是一种好做法。有不少分析师报道了该股,因此你可以很容易地研究预测的增长。

Insider Ownership Of Shandong Weigao Group Medical Polymer

山东威高集团医用聚合物的内部所有权

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

尽管内部人士的确切定义可能是主观的,但几乎每个人都认为董事会成员是内部人士。管理层最终对董事会负责。但是,经理成为执行委员会成员的情况并不少见,尤其是当他们是创始人或首席执行官时。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

当内部所有权表明领导层像公司的真正所有者一样思考时,内部所有权是积极的。但是,高度的内部所有权也可以赋予公司内部的一小部分人巨大的权力。在某些情况下,这可能是负面的。

Our information suggests that Shandong Weigao Group Medical Polymer Company Limited insiders own under 1% of the company. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. It is a pretty big company, so it would be possible for board members to own a meaningful interest in the company, without owning much of a proportional interest. In this case, they own around HK$41m worth of shares (at current prices). Arguably, recent buying and selling is just as important to consider. You can click here to see if insiders have been buying or selling.

我们的信息表明,山东威高集团医用聚合物有限公司内部人士拥有该公司不到1%的股份。但是,我们确实注意到,内部人士有可能通过私营公司或其他公司结构获得间接利益。这是一家相当大的公司,因此董事会成员有可能在不拥有太多比例权益的情况下拥有该公司的有意义的权益。在这种情况下,他们拥有价值约4100万港元的股票(按当前价格计算)。可以说,最近的买入和卖出同样值得考虑。你可以点击这里查看内部人士是否在买入或卖出。

General Public Ownership

一般公有制

With a 29% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shandong Weigao Group Medical Polymer. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

山东威高集团拥有29%的所有权,主要由个人投资者组成的公众对山东威高集团医用聚合物有一定程度的影响力。尽管这个群体不一定能做主,但它肯定会对公司的运作方式产生真正的影响。

Private Company Ownership

私人公司所有权

Our data indicates that Private Companies hold 46%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我们的数据显示,私营公司持有公司46%的股份。可能值得对此进行更深入的研究。如果关联方,例如内部人士,对其中一家私营公司有兴趣,则应在年度报告中予以披露。私营公司也可能在公司中拥有战略利益。

Next Steps:

后续步骤:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Shandong Weigao Group Medical Polymer , and understanding them should be part of your investment process.

尽管值得考虑拥有公司的不同群体,但还有其他因素更为重要。例如,投资风险的幽灵无处不在。我们已经确定了山东威高集团医用聚合物的一个警告信号,了解它们应该成为您投资过程的一部分。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果你想了解分析师对未来增长的预测,千万不要错过这份关于分析师预测的免费报告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗?直接联系我们。或者,发送电子邮件给编辑组(网址为)simplywallst.com。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发